Immunofluorescence micrograph demonstrated that the FITC-labeled nanoparticles colocalized with SPARC in tumor (Fig. 6a, lower row), supporting the tumor targeting effect of BPBBT NPs through the albumin-SPARC binding33,34. The gene discussed is SPARC; the disease is neoplasm.